{"id":"W4387094998","doi":"10.21203/rs.3.rs-3314138/v1","title":"Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institutes of Health; Ovarian Cancer Research Alliance; Astex Pharmaceuticals; Sierra Oncology; Uehara Memorial Foundation; Japan Society for the Promotion of Science; AstraZeneca; Hope Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","keywords":"ARID1A; RAD51; Cancer research; DNA damage; Chromatin; DNA repair; Biology; Synthetic lethality; Homologous recombination; Epigenetics; Cancer; BRD4; Wee1; Cell cycle; Mutation; DNA; Gene; Genetics; Cyclin-dependent kinase 1","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002551044,0.0002026665,0.0003731441,0.0003252008,0.000204357,0.0004837773,0.0003018133,0.0003531328,0.002878218],"category_scores_gemma":[0.0001915969,0.0002238215,0.0002873797,0.0002650635,0.000361824,0.0002974785,0.0003266805,0.0008106414,0.0005510592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003509225,"about_ca_system_score_gemma":0.0004228842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006186984,"about_ca_topic_score_gemma":0.0009676426,"domain_scores_codex":[0.9998111,0.00002644606,0.0000158778,0.00003248717,0.00005456487,0.00005953859],"domain_scores_gemma":[0.9999033,0.00001775458,0.00002199529,0.00001892335,0.000008279797,0.00002973704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007945374,0.0001076241,0.0005543885,0.00006520461,0.0000268391,0.0001172572,0.0000187971,0.0002793372,0.9923176,0.0007743801,0.0003580755,0.004586051],"study_design_scores_gemma":[0.0001255114,0.0004605067,0.004020649,0.000004049666,0.00004374465,0.0004394444,0.0000455524,0.002058395,0.9847816,0.0003080388,0.007705476,0.000007016091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900689,0.002036027,0.002942687,0.0004350457,0.00009669954,0.00003673039,0.001104931,0.0001741543,0.00310495],"genre_scores_gemma":[0.9940917,0.0006251247,0.001294805,0.00006378819,0.000009667643,0.00003515721,0.0005302324,0.00003812899,0.003311307],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002878218,"threshold_uncertainty_score":0.009628594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08011353551033792,"score_gpt":0.3738866789865019,"score_spread":0.2937731434761639,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}